BrainStorm Cell Therapeutics , a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that Mayo Clinic in Rochester, Minnesota has entered into a Memorandum of Understanding with the intent to conduct a Phase II clinical trial of NurOwn in amyotrophic lateral sclerosis , more commonly known as Lou ... (more)
http://www.biospace.com/news_story.aspx?StoryID=290769&full=1
http://www.biospace.com/news_story.aspx?StoryID=290769&full=1
No comments:
Post a Comment